{
  "case_id": "case_0061",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 47.63,
    "sex": "Female",
    "genderIdentity": "Cisgender Male",
    "ancestry": "Sub-Saharan African"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- left pons.\n  \nAdditional signs indicate lesion possibly also involving:\n- left medulla.",
      "structured_data": {
        "gt_lesions_english": [
          "left medulla",
          "left pons"
        ],
        "ft_lesions_parsed": [
          {
            "location": "lateral pons",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left pons"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [
          "left medulla"
        ],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 1,
        "additional_lesion_count": 0,
        "proportion_correct": 0.5,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.5,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- Intracerebral Haemorrhage, Brainstem Tumour (Primary or Metastatic), Cavernous Malformation and Brainstem Infarct / Vertebral Artery Dissection.\n\nOther possible differentials:\n- NMOSD (AQP4+), MOGAD, Neurosarcoid, SLE, Neurosyphilis and Listeria.\n- Also feasible but of low probability: TB, Beh\u00e7et's, Lyme, Leptomeningeal carcinomatosis, Vasculitis, Lymphoma and Brainstem Abscess.",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Left lateral pontine infarct (AICA territory ischemic stroke)",
          "Left pontine parenchymal haemorrhage",
          "Demyelinating brainstem plaque due to multiple sclerosis",
          "Brainstem cavernous malformation with recent haemorrhage",
          "Intrinsic brainstem glioma"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "Brain_Haemorrhage",
          "Brainstem_Tumour",
          "Cavernous_Malformation",
          "MS",
          "Brain_Infarct_Brainstem"
        ],
        "missing_lesion_dx_keys": [
          "CNS_Tuberculosis",
          "Behcet_Disease",
          "Infection_Lyme",
          "Leptomeningeal_Carcinomatosis",
          "Syphilis",
          "Listeria_Rhombencephalitis",
          "AQP4_NMOSD",
          "Neurosarcoidosis",
          "CNS_Vasculitis",
          "Autoimmune_Myelitis_SLE",
          "CNS_Lymphoma",
          "MOGAD",
          "Brain_Abscess_Brainstem"
        ],
        "missing_common_names": [
          "Neurosyphilis",
          "Listeria",
          "NMOSD (AQP4+)",
          "Neurosarcoid",
          "SLE",
          "MOGAD"
        ],
        "missing_low_prob_names": [
          "TB",
          "Beh\u00e7et's",
          "Lyme",
          "Leptomeningeal carcinomatosis",
          "Vasculitis",
          "Lymphoma",
          "Brainstem Abscess"
        ],
        "additional_diagnoses": []
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 0,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 18,
        "lesion_ddx_matched_count": 5,
        "lesion_ddx_missed_common_count": 6,
        "lesion_ddx_missed_low_prob_count": 7,
        "lesion_ddx_coverage_percentage": 0.2777777777777778
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Brain and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-MOG, ANA, CRP, anti-AQP4, ENA, ANCA, ESR.\n- Could also consider testing: anti-dsDNA, TB, ACE, HIV, syphilis, lyme, CSF (flow cytometry, PCR for Listeria and cytology).",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "Non-contrast CT brain",
          "CT angiogram of head and neck",
          "MRI brain with brainstem-focused sequences and diffusion-weighted imaging",
          "MR angiogram of intracranial and neck vessels",
          "ECG",
          "Continuous cardiac telemetry monitoring",
          "Transthoracic echocardiogram",
          "Carotid and vertebral artery duplex ultrasound",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "Coagulation screen",
          "Blood glucose",
          "HbA1c",
          "Lipid profile",
          "Erythrocyte sedimentation rate",
          "C-reactive protein",
          "Thyroid function tests",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Antineutrophil cytoplasmic antibodies",
          "Aquaporin-4 antibody",
          "Myelin oligodendrocyte glycoprotein (MOG) antibody",
          "Lumbar puncture with CSF cell count, protein, glucose, oligoclonal bands and IgG index (after imaging excludes mass effect)",
          "MRI of whole spinal cord with contrast"
        ],
        "all_identified_ft_keys": [
          "Lipid_Profile",
          "MOG_Antibodies",
          "CRP",
          "TFT",
          "Coagulation_Screen",
          "ENA_Panel",
          "LFT",
          "ECG",
          "Glucose_HbA1c",
          "U_and_E",
          "AQP4_Antibodies",
          "CSF_Oligoclonal_Bands",
          "Serum_Immunoglobulins",
          "CSF_General",
          "FBC",
          "ANA",
          "MRI_Whole_Spine",
          "MRI_Lumbosacral_Spine",
          "Cerebral_Angiography",
          "MRI_Cervical_Spine",
          "MRI_Thoracic_Spine",
          "ANCA",
          "MRA_Head_Neck",
          "Carotid_Doppler",
          "MRI_Brain",
          "ESR",
          "Cardiac_Telemetry",
          "CT_Head"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "ANA",
          "CRP",
          "MOG_Antibodies",
          "CSF_Listeria_PCR",
          "TB_Screen",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "CSF_Cytology",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "AQP4_Antibodies",
          "ENA_Panel",
          "ANCA",
          "ESR"
        ],
        "missing_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "CSF_Listeria_PCR",
          "TB_Screen",
          "Serum_ACE",
          "HIV_Test",
          "CSF_Cytology",
          "Syphilis_Serology",
          "Lyme_Serology"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 2,
        "primary_tests_found_count": 2,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 16,
        "ddx_tests_found_count": 7,
        "ddx_tests_coverage_percentage": 0.4375
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Appropriate to consider but delay treatment.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint is not specified, so no indication what the current issue is and whether neurological signs are new or old.\n\n- Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Inappropriate omission. The plan failed to consider this possible treatment option.\n  \nAdditional factors not mentioned:\n\n- Need confirmation of MS diagnosis.\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Urgent admission to a stroke unit with close neurological and cardiorespiratory monitoring",
            "timing": "Start Now",
            "reasons": [
              "High risk of early neurological deterioration in brainstem strokes",
              "Need for frequent observation, airway protection readiness, and blood pressure management"
            ]
          },
          {
            "treatment": "Intravenous thrombolysis with alteplase or tenecteplase if within guideline time window and no contraindications",
            "timing": "Start Now",
            "reasons": [
              "Clinical picture strongly suggests an acute disabling ischaemic pontine stroke",
              "Thrombolysis improves outcome when given rapidly after onset and haemorrhage is excluded on CT"
            ]
          },
          {
            "treatment": "Mechanical thrombectomy for vertebrobasilar large-vessel occlusion if demonstrated on vascular imaging",
            "timing": "Start Now",
            "reasons": [
              "Brainstem strokes from basilar occlusion have high morbidity and mortality without reperfusion",
              "Endovascular therapy offers benefit up to extended time windows when salvageable tissue is present"
            ]
          },
          {
            "treatment": "Aspirin 300 mg daily (or equivalent antiplatelet regimen)",
            "timing": "Delay",
            "reasons": [
              "Must await imaging to exclude intracranial haemorrhage",
              "If thrombolysis is given, antiplatelets are delayed for 24 hours to limit haemorrhagic transformation risk"
            ]
          },
          {
            "treatment": "High-intensity statin therapy (e.g., atorvastatin 40\u201380 mg nightly)",
            "timing": "Delay",
            "reasons": [
              "Initiated after acute stabilisation and once swallowing is assessed",
              "Provides secondary prevention of ischaemic stroke regardless of baseline cholesterol"
            ]
          },
          {
            "treatment": "Blood pressure management according to acute stroke guidelines",
            "timing": "Start Now",
            "reasons": [
              "Avoids both hypo- and hypertension, which can worsen ischaemic penumbra or provoke haemorrhagic transformation",
              "Specific thresholds are required before and after thrombolysis or thrombectomy"
            ]
          },
          {
            "treatment": "Swallowing assessment, aspiration precautions, and early nutritional support (oral texture modification or nasogastric feeding)",
            "timing": "Start Now",
            "reasons": [
              "Cranial nerve involvement places the patient at high risk for aspiration",
              "Early nutrition and hydration improve recovery and reduce complications"
            ]
          },
          {
            "treatment": "Venous thromboembolism prophylaxis with intermittent pneumatic compression and, once haemorrhage is excluded, low-molecular-weight heparin if not contraindicated",
            "timing": "Start Now",
            "reasons": [
              "Hemiparesis and reduced mobility confer high DVT and PE risk",
              "Mechanical prophylaxis can be started immediately; pharmacological prophylaxis follows haemorrhage exclusion"
            ]
          },
          {
            "treatment": "Multidisciplinary neurorehabilitation (physiotherapy, occupational therapy, speech and language therapy)",
            "timing": "Delay",
            "reasons": [
              "Commenced as soon as the patient is haemodynamically stable, usually within 24\u201348 hours",
              "Essential for maximising functional recovery from hemiparesis and ataxia"
            ]
          },
          {
            "treatment": "High-dose intravenous methylprednisolone course if MRI and CSF support demyelinating disease rather than stroke",
            "timing": "Delay",
            "reasons": [
              "Steroids are not indicated for ischaemic stroke and should be reserved for confirmed inflammatory/demyelinating pathology",
              "Avoids masking infection or neoplasm until diagnosis is clear"
            ]
          },
          {
            "treatment": "Long-term vascular risk factor modification (antihypertensives, diabetes optimisation, smoking cessation, lifestyle counselling)",
            "timing": "Delay",
            "reasons": [
              "Instituted after acute phase to reduce recurrence risk",
              "Requires outpatient follow-up and patient engagement in chronic disease management"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone course if MRI and CSF support demyelinating disease rather than stroke",
            "timing": "Delay",
            "reasons": [
              "Steroids are not indicated for ischaemic stroke and should be reserved for confirmed inflammatory/demyelinating pathology",
              "Avoids masking infection or neoplasm until diagnosis is clear"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint is not specified, so no indication whether this is related to MS.",
                "Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint is not specified, so no indication what the current issue is and whether neurological signs are new or old.\n\n- Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": null,
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Need a pregnancy test result.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Inappropriate omission. The plan failed to consider this possible treatment option.\n  \nAdditional factors not mentioned:\n\n- Need confirmation of MS diagnosis.\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 3,
          "reasons_acknowledged": 0,
          "reasons_missed": 3,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "inappropriate_omission",
          "is_unsafe": 1,
          "reasons_total": 3,
          "reasons_acknowledged": 0,
          "reasons_missed": 3,
          "reasons_coverage_percentage": 0.0
        }
      }
    }
  }
}